Spatial heterogeneity of tumour blood flow modification induced by angiotensin II: Relationship to receptor distribution

International Journal of Cancer

Volumn 65, Issue 5, 1996, Pages 658-663

  Tozer, Gillian M ^a   Shaffi, Katija M ^a   Prise, Vivien E ^a   Bell, Katrina M ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CARBON 14; MICROSPHERE I 125;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; TUMOR BLOOD FLOW;

ANGIOTENSIN II; ANIMALS; CARCINOSARCOMA; HUMANS; RATS; RECEPTORS, ANGIOTENSIN; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE;

EID: 0030012282     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960301)65:5<658::AID-IJC16>3.0.CO;2-3     Document Type: Article

References (31)

1. ANDERSON, N.H., WILLMOTT, N., BESSENT, R., ANGERSON, W.J., KERR, D.J. and MCARDLE, C.S., Regional chemotherapy for inoperable renal carcinoma: a method of targeting therapeutic microspheres to tumour. Brit. J. Cancer, 64, 365-368 (1991).
2. 2 receptor subtype expression by differentiation of the neuroblastoma × glioma hybrid, NG-1080-15. Europ. J. Pharmacol., 225, 119-127 (1992).
3. CHEN, L., PRAKASH, O. and RE, R.N., The interaction of insulin and angiotensin II on the regulation of human neuroblastoma cell growth. Mol. chem. Neuropathol., 18, 189-196 (1993).
4. GEHLERT, D.R., SPETH, R.C. and WAMSLEY, J.K., Autoradiographic localisation of angiotensin II receptors in the rat brain and kidney. Europ. J. Pharmacol., 98, 145-146 (1984).
5. 125I]angiotensin II binding in the rat brain: a quantitative autoradiographic study. Neuroscience, 18, 837-856 (1986).
6. GRÖNE, H.-J., SIMON, M. and FUCHS, E., Autoradiographic characterization of angiotensin receptor sub-types in fetal and adult human kidney. Amer. J. Physiol., 262 (Renal Fluid Electrolyte Physiol., 31), F326-F331 (1992).
7. HEMINGWAY, D.M., ANGERSON, W.J., ANDERSON, J.H., GOLDBERG, J.A., MCARDLE, C.S. and COOKE, T.G., Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II. Brit. J. Cancer. 66, 958-960 (1992)
8. HORI, K., SUZUKI, M., TANDA, S., SAITO, S., SHINOZAKI, M. and ZHANG, Q.H., Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension. Jpn. J. Cancer Res., 82, 1309-1316 (1991).
9. JIRTLE, R., CLIFTON, K.H. and RANKIN, J.H.G., Effects of several vasoactive drugs on the vascular resistance of MT-W9B tumours in W/Fu rats. Cancer Res., 38, 2385-2390 (1978).
10. KERR, D.J., GOLDBERG, J.A., ANDERSON, J.R., WILMOTT, N., WHATELEY, A.T., MCARDLE, C.S. and MCKILLOP, J., The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs. EXS. 61, 340-345 (1992).
11. KETY, S.S., Theory of blood tissue exchange and its application to measurements of blood flow. Meth. med Res., 8, 223-227 (1960).
12. KOBAYASHI, H., HASUDA, K., AOKI, K., TANIGUCHI, S. and BABA, T., Systemic chemotherapy in tumour-bearing rats using high-dose cis-diamminedichloroplatinum (II) with low nephrotoxicity in combination with angiotensin II and sodium thiosulfate. Int J. Cancer. 45, 940-944 (1990).
13. KOBAYASHI, H., HASUDA, K., TANIGUCHI, S. and BABA, T., Therapeutic efficacy of two-route chemotherapy using cis-diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, combined with the angiotensin-II-induced hypertension method in a rat uterine tumor. Int. J. Cancer, 47, 893-898 (1991).
14. MATTHEWS, J.C., Fundamentals of receptor, enzyme, and transport kinetics, CRC Press. Boca Raton, Florida (1993).
15. MUTOH, S., AIKOU, I., SOEJIMA, K., UEDA, S., FUKUSHIMA, S., KISHIMOTO, S. and TAKAGI, Y., Local control of prostate cancer by intraarterial infusion chemotherapy facilitated by the use of angiotensin II. Urol Int., 48, 175-180 (1992).
16. NOGUCHI, S., MIYAUCHI, K., NISHIZAWA, Y., SASAKI, Y., IMAOKO, S., IWANAGA, T., KOYAMA, H. and TERASAWA, T., Augmentation of anti-cancer effect with angiotensin II in intra-arterial infusion chemotherapy for breast carcinoma. Cancer, 62, 467-473 (1988).
17. REAGAN, L.P., FLANAGAN-CATO, L.M., YEE, D.K., MA, L.Y., SAKAI, R.R. and FLUHARTY, S.J., Immunohistochemical mapping of angiotensin type 2 (AT2) receptors in rat brain. Brain Res., 662, 45-59 (1994).
18. SIMANTOV, R., SNOWMAN, A.M. and SNYDER, S.H., Temperature and ionic influences on opiate receptor binding Mol. Pharmacol., 12. 977-986 (1976).
19. SITZMANN, J.V., WU, Y. and CAMERON, J.L., Altered angiotensin-II receptors in human hepatocellular and hepatic metastatic colon cancers. Ann. Surg., 219, 500-507 (1994).
20. SUZUKI, M., HORI, K., ABE, I., SAITO, S. and SATO, H., A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II. J. nat. Cancer Inst , 67, 663-669 (1981).
21. TAKEMATSU, H., TOMITA, Y. and KATO, T., Angiotensin-induced hypertension and chemotherapy for multiple lesions of malignant melanoma. Brit. J. Dermatol., 113, 463-465 (1985).
22. TANDA, S., HORI, K., SAITO, S., SHINOZAKI, M., ZHANG, Q.H. and SUZUKI, M., Comparison of the effects of intravenously bolus-administered endothelin-I and infused angiotensin II on the subcutaneous tumor blood flow in anaesthetized rats. Jpn. J. Cancer Res., 82, 958-963 (1991).
23. 2 supply. Acta Oncol., 34, 291-295 (1995).
24. TIMMERMANS, P.M.W.M., CHIU, A.T., HERBLIN, W.F., WONG, P C. and SMITH, R.D., Angiotensin II receptor sub-types. Amer. J. Hypertension, 5, 406-410 (1992).
25. TOKUDA, K., ABE, H., AIDA, T., SUGIMOTO, S. and KANEKO, S., Modification of tumor blood flow and enhancement of therapeutic effect of ACNU on experimental rat gliomas with angiotensin II. J. Neurooncol., 8, 205-212 (1990).
26. TOZER, G.M. and MORRIS, C., Blood flow and blood volume in a transplanted rat fibrosarcoma: comparison with various normal tissues. Radiother. Oncol., 17, 153-166 (1990).
27. TOZER, G.M. and SHAFFI, K.M., Modification of tumour blood flow using the hypertensive agent, angiotensin II Brit. J. Cancer, 67, 981-988 (1993).
28. TOZER, G.M. and SHAFFI, K.M., The response of tumour vasculature to angiotensin II revealed by its systemic and local administration to "tissue-isolated" tumours. Brit. J. Cancer 72, 595-600 (1995).
29. TOZER, G.M., SHAFFI, K.M. and HIRST, D.G., Use of the hypertensive agent angiotensin II for modifying oxygen delivery to tumours. In: P. Vaupel (ed.), Oxygen transport to tissue XV. pp. 423-429. Plenum Press. New York (1994a).
30. TOZER, G.M., SHAFFI, K.M., PRISE, V.E. and CUNNINGHAM, V.J., Characterisation of tumour blood flow using a "tissue-isolated" preparation. Brit. J. Cancer. 70, 1040-1046 (1994b).
31. TROTTER, M.J., CHAPLIN, D.J. and OLIVE, P.L., Effect of angiotensin II on intermittent tumour blood flow and acute hypoxia in the murine SCCVII carcinoma. Europ. J Cancer. 27, 887-893 (1991).